NVS' first-quarter performance has likely benefited from strong growth in Kisqali, Kesimpta, Pluvicto, Leqvio, Scemblix and ...

Amid rising US-China trade tensions, AdAlta aims to be a gateway for Asia's next wave of cellular immunotherapies to enter ...

Mumbai: Considering that the "epidemic" of cardiovascular diseases (CVD) is responsible for over 25% of the annual deaths in ...

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV commercials in the first quarter compared to the same period a year ago. | ...

When Novartis announced it was teaming up with the NFL last month, the company called it the first-ever corporate pharmaceutical partnership with the league. But it wasn’t exactly the only matchup ...

Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify ...

It binds both transmembrane and soluble TREM2, triggering a rise in CSF sTREM2. Single and multi-dose studies of the small ...

Real Chemistry, a 2024 MM+M Agency 100 honoree, appointed Cali Howitt, PhD, as president of U.S. medical and executive leader for its promotional and medical affairs business in the U.S. General ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

"The quantity of ctDNA detected was important," Polsky told MedPage Today. "The higher the level of ctDNA, the greater the ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...